People

Des Jarlais
Don C. Des Jarlais, PhD
CDUHR - Associate Director, Infectious Disease Epidemiology and Social-behavioral Theory Core
NYU School of Global Public Health - Professor
Education
PhD, Social Psychology, University of Michigan, Ann Arbor
BA, Behavioral Science, Rice University
Research Interests
Injecting drug use, Epidemiology, HIV, HCV, Research synthesis
BIO
For over 30 years Don Des Jarlais has been conducting HIV/AIDS research among persons who inject drugs (PWID). He is PI of the “Risk Factors” study (R01DA003574), which was instrumental in tracking the HIV/AIDS epidemic in New York City. This study has been funded by the National Institute on Drug Abuse since 1983 and is the longest continuously funded study on HIV/AIDS in persons who use drugs. He has conducted HIV/AIDS research nationally (Seattle, CDC CIDUS studies, national syringe exchange survey) and internationally (in over 20 different countries). He has served as a consultant on these issues to the World Health Organization, the National Institutes of Health and the U.S. Centers for Disease Control and Prevention.
Projects
Principal Investigator, Combined Prevention to Reduce Initiation Into Injecting Drug Use. Active
Principal Investigator, DRIVE (Drug Use and Blood-Borne Infections in Vietnam): Combined Prevention and Care to End the HIV Epidemic Among People Who Inject Drugs in Haiphong, Vietnam. Active
Principal Investigator, Risk Factors for AIDS among Persons Who Inject Drugs: HIV and COVID-19. Active
Principal Investigator, Barriers to Reason: Laws Impacting HIV Prevention Efforts among IDUs in the United States. Completed
Principal Investigator, Combined HIV Prevention for PWID and Future Collaborative Research in Vietnam. Completed
Principal Investigator, Evaluating ART for All HIV Seropositives: Can It Work with the Hardest Cases?. Completed
Principal Investigator, Expanded Syringe Access Program: NY Evaluation (ESAP). Completed
Principal Investigator, HIV Infection in Ethnic Minority IDUs: An International Systematic Review. Completed
Principal Investigator, HIV Transmission among Injecting and Non-Injecting Drug Users in Tallinn, Estonia. Completed
Principal Investigator, Multiple HIV Prevention Packages for IDUs in Estonia. Completed
Principal Investigator, National Study of Syringe Exchange Programs. Completed
Principal Investigator, WHO Survey Coordinating Center, Drug Injecting Study – Phase 2. Completed
Publications

Recent

Des Jarlais D, Bobashev G, Feelemyer J, McKnight C (2022).
Modeling HIV transmission among persons who inject drugs (PWID) at the “End of the HIV Epidemic” and during the COVID-19 pandemic
Drug and Alcohol Dependence, 238, 109573. doi: 10.1016/j.drugalcdep.2022.109573.

Huong DT, Moles JP, Khue PM, Vallo R, Giang HT, Vinh VH, Oanh KTH, Thanh NTT, Nguyen DQ, Quillet C, Rapoud D, Van de Perre P, Castellani J, Feelemyer J, Michel L, Laureillard D, Des Jarlais D, Nagot N (2022).
A community-based intervention to decrease the prevalence of HIV viremia among people who inject drugs in Vietnam
Lancet Regional Health - Western Pacific, 27, 100538. doi: 10.1016/j.lanwpc.2022.100538. PMCID: PMC9287471.

Frost MC, Austin EJ, Corcorran MA, Briggs ES, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN (2022).
Responding to a surge in overdose deaths: Perspectives from US syringe services programs
Harm Reduction Journal, 19 (1), 79. doi: 10.1186/s12954-022-00664-y. PMCID: PMC9295104.

Durand M, Nagot N, Michel L, Le SM, Huong DT, Vallo R, Vizeneux A, Rapoud D, Giang HT, Quillet C, Thanh NTT, Oanh KTH, Vinh VH, Feelemyer J, Vande Perre P, Minh KP, Laureillard D, Des Jarlais D, Moles JP (2022).
Mental disorders are associated with leukocytes telomere shortening among people who inject drugs
Frontiers in Psychiatry, 13, 846844. doi: 10.3389/fpsyt.2022.846844. PMCID: PMC9247253.

Choi J, Lieff SA, Meltzer GY, Grivel MM, Chang VW, Yang LH, Des Jarlais DC (2022).
Anti-vaccine attitudes among adults in the U.S. during the COVID-19 pandemic after vaccine rollout
Vaccines, 10 (6), 933. doi: 10.3390/vaccines10060933. PMCID: PMC9228411.


Notable

Des Jarlais DC, Huong DT (2018).
Ending HIV epidemics among people who inject drugs in LMICs
Lancet, 392 (10149), 714-719. doi: 10.1016/S0140-6736(18)31721-5.

Dr. Des Jarlais' ResearchGate Profile
Selected Press